『Optimizing Treatment in Patients with ROS1 Rearranged NSCLC』のカバーアート

Optimizing Treatment in Patients with ROS1 Rearranged NSCLC

Optimizing Treatment in Patients with ROS1 Rearranged NSCLC

著者: Annenberg Center for Health Sciences
無料で聴く

このコンテンツについて

Greater understanding and implementation of molecular biomarkers in non-small cell lung cancer (NSCLC) have led to improved patient outcomes. However, optimizing therapeutic strategies for patients with a molecular alteration continues to be challenging for the multidisciplinary team. Among these alterations, ROS1 rearrangements are rare, but have important clinical implications.Annenberg Center for Health Sciences 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Introduction and Key Takeaways
    2024/10/07

    This full educational program can be accessed at no cost here: https://annenberg.net/courses/landingPage.php?courseID=61030

    続きを読む 一部表示
    15 分

Optimizing Treatment in Patients with ROS1 Rearranged NSCLCに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。